Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
DKB-19002 by DongKoo Bio & Pharma for Type 2 Diabetes: Likelihood of Approval
DKB-19002 is under clinical development by DongKoo Bio & Pharma and currently in Phase I for Type 2 Diabetes. According...
OOF by DongKoo Bio & Pharma for Hypertension: Likelihood of Approval
OOF is under clinical development by DongKoo Bio & Pharma and currently in Phase I for Hypertension. According to GlobalData,...
OOF by DongKoo Bio & Pharma for Idiopathic (Essential) Hypertension: Likelihood of Approval
OOF is under clinical development by DongKoo Bio & Pharma and currently in Phase I for Idiopathic (Essential) Hypertension. According...